1. Home
  2. ASIC vs SVRA Comparison

ASIC vs SVRA Comparison

Compare ASIC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ategrity Specialty Insurance Company Holdings

ASIC

Ategrity Specialty Insurance Company Holdings

SELL

Current Price

$24.36

Market Cap

1.3B

Sector

Finance

ML Signal

SELL

Logo Savara Inc.

SVRA

Savara Inc.

SELL

Current Price

$4.46

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
ASIC
SVRA
Founded
2018
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2025
2009

Fundamental Metrics

Financial Performance
Metric
ASIC
SVRA
Price
$24.36
$4.46
Analyst Decision
Buy
Strong Buy
Analyst Count
5
9
Target Price
★ $28.40
$11.06
AVG Volume (30 Days)
73.7K
★ 2.8M
Earning Date
10-21-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 23.44
N/A
EPS
★ 1.47
N/A
Revenue
★ $424,339,000.00
N/A
Revenue This Year
$24.89
N/A
Revenue Next Year
$22.34
$4,204.68
P/E Ratio
$16.69
★ N/A
Revenue Growth
★ 23.41
N/A
52 Week Low
$16.73
$4.13
52 Week High
$29.00
$7.01

Technical Indicators

Market Signals
Indicator
ASIC
SVRA
Relative Strength Index (RSI) 45.26 41.93
Support Level $23.36 $4.23
Resistance Level $25.62 $5.47
Average True Range (ATR) 0.84 0.30
MACD 0.08 -0.00
Stochastic Oscillator 62.35 14.20

Price Performance

Historical Comparison
ASIC
SVRA

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: